Marshall Wace
WVE icon

Marshall Wace’s Wave Life Sciences WVE Stock Holding History

Marshall Wace’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.81M Sell
999,533
-790,349
-44% -$5.24M ﹤0.01% 1293
2026
Q1 		$13M Buy
+1,789,882
New +$23.3M 0.01% 857
2025
Q4 		– Sell
-14,000
Closed -$102K – 3548
2025
Q3 		$102K Sell
14,000
-10,828
-44% -$87.6K ﹤0.01% 2656
2025
Q2 		$161K Buy
+24,828
New +$164K ﹤0.01% 2490
2025
Q1 		– Sell
-183,875
Closed -$2.27M – 3146
2024
Q4 		$2.27M Buy
183,875
+55,325
+43% +$738K ﹤0.01% 1383
2024
Q3 		$1.05M Buy
128,550
+66,448
+107% +$397K ﹤0.01% 1631
2024
Q2 		$310K Sell
62,102
-251,303
-80% -$1.43M ﹤0.01% 2141
2024
Q1 		$1.93M Sell
313,405
-186,804
-37% -$935K ﹤0.01% 1379
2023
Q4 		$2.53M Buy
500,209
+318,571
+175% +$1.7M ﹤0.01% 1128
2023
Q3 		$1.04M Sell
181,638
-42,518
-19% -$194K ﹤0.01% 1488
2023
Q2 		$816K Sell
224,156
-145,334
-39% -$587K ﹤0.01% 1804
2023
Q1 		$1.6M Buy
369,490
+42,040
+13% +$193K ﹤0.01% 1575
2022
Q4 		$2.29M Buy
+327,450
New +$1.51M 0.01% 1654
2020
Q4 		– Sell
-46,481
Closed -$395K – 2221
2020
Q3 		$395K Buy
+46,481
New +$509K ﹤0.01% 1297
2019
Q2 		– Sell
-59,629
Closed -$2.32M – 1903
2019
Q1 		$2.32M Buy
+59,629
New +$2.42M 0.02% 698
2017
Q1 		– Sell
-29,822
Closed -$780K – 779
2016
Q4 		$780K Buy
+29,822
New +$970K 0.01% 789

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GP
GSK plc London $602M AUM
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RAM
Readystate Asset Management Chicago, Illinois $2.93B AUM 18.57% 1-Year Est. Return

Marshall Wace's WVE Position: Q2 2026 in Review

Marshall Wace reduced its Wave Life Sciences (WVE) stake by 44% in Q2 2026, selling an estimated $5.24M and leaving 999,533 shares worth $5.81M. The position accounts for ﹤0.01% of the portfolio, ranked #1293.

Marshall Wace first reported a position in WVE in Q4 2016 and has held it in 16 quarters since. The position peaked at $13M in Q1 2026. 239 funds tracked by Wall St. Rank hold WVE as of Q2 2026.

  • Marshall Wace held 999,533 shares of Wave Life Sciences worth $5.81M as of Q2 2026.
  • Marshall Wace sold 790,349 Wave Life Sciences shares in Q2 2026, an estimated $5.24M.
  • Wave Life Sciences made up ﹤0.01% of Marshall Wace's portfolio in Q2 2026, its #1293 holding.
  • Marshall Wace first reported a position in Wave Life Sciences in Q4 2016 and has held it in 16 quarters since.
  • Marshall Wace's Wave Life Sciences position peaked at $13M in Q1 2026.
  • 239 funds tracked by Wall St. Rank held Wave Life Sciences as of Q2 2026.

Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.